Literature DB >> 15539405

1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.

Kimie Nakagawa1, Akihiko Kawaura, Shigeaki Kato, Eiji Takeda, Toshio Okano.   

Abstract

1alpha,25-Dihydroxyvitamin D(3) [1alpha,25(OH)(2)D(3)], the major regulator of calcium homeostasis, has potent antiproliferative and anti-invasive properties in vitro in cancer cells. Studies in vivo demonstrated that 1alpha,25(OH)(2)D(3) slows the progression of breast, prostate and other carcinomas. A key question is whether 1alpha,25(OH)(2)D(3) exerts its anticarcinogenic effects in vivo by a mechanism that is dependent on its capacity to limit the proliferation and invasiveness of cancer cells in vitro. It has not been clear whether the calcemic activity and regulation of the host defenses by 1alpha,25(OH)(2)D(3) contribute to the effect on cancer cells. In this study we have focused on the influence of 1alpha,25(OH)(2)D(3) on the metastasis of lung cancer, without involvement of the calcemic activity and other effects of 1alpha,25(OH)(2)D(3) in the host. We used metastatic Lewis lung carcinoma cells expressing green fluorescent protein (LLC-GFP cells) and examined metastatic activity in vitamin D receptor (VDR) null mutant (VDR(-/-)) mice and their wild-type counterparts (VDR(+/+) mice). VDR(-/-) mice exhibit hypocalcemia and extremely high serum levels of 1alpha,25(OH)(2)D(3). We expected that serum 1alpha,25(OH)(2)D(3) would act in vivo to directly inhibit the metastatic growth of VDR-positive LLC-GFP cells in VDR(-/-) mice. The metastatic activities of LLC-GFP cells were remarkably reduced in VDR(-/-) mice compared with VDR(+/+) mice. To test the hypothesis that serum 1alpha,25(OH)(2)D(3) is an intrinsic factor that inhibits metastatic growth of lung cancer cells, we corrected hypocalcemia and/or hypervitaminosis D in VDR(-/-) mice by dietary manipulation. The metastatic growth of LLC-GFP cells was remarkably reduced in response to serum levels of 1alpha,25(OH)(2)D(3), but not to serum calcium levels. Furthermore, we found that VDR(+/+) mice fed the manipulated diets displayed an apparent inverse relationship between the physiological levels of serum 1alpha,25(OH)(2)D(3) (8-15 pg/ml) and tumorigenesis. Here we show that 1alpha,25(OH)(2)D(3) inhibits the metastatic growth of lung cancer cells in a defined animal model.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15539405     DOI: 10.1093/carcin/bgh332

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  44 in total

Review 1.  The role of vitamin D in hepatic metastases from colorectal cancer.

Authors:  E Shaw; N Massaro; N T Brockton
Journal:  Clin Transl Oncol       Date:  2017-08-11       Impact factor: 3.405

2.  Vitamin D derivatives enhance cytotoxic effects of H2O2 or cisplatin on human keratinocytes.

Authors:  Anna Piotrowska; Justyna Wierzbicka; Tomasz Ślebioda; Michał Woźniak; Robert C Tuckey; Andrzej T Slominski; Michał A Żmijewski
Journal:  Steroids       Date:  2016-04-13       Impact factor: 2.668

3.  Serum vitamin D, vitamin D binding protein, and lung cancer survival.

Authors:  Gabriella M Anic; Stephanie J Weinstein; Alison M Mondul; Satu Männistö; Demetrius Albanes
Journal:  Lung Cancer       Date:  2014-10-20       Impact factor: 5.705

Review 4.  Role of vitamin D in uterine fibroid biology.

Authors:  Soumia Brakta; Justin S Diamond; Ayman Al-Hendy; Michael P Diamond; Sunil K Halder
Journal:  Fertil Steril       Date:  2015-06-13       Impact factor: 7.329

5.  JAM-C promotes lymphangiogenesis and nodal metastasis in non-small cell lung cancer.

Authors:  SongNan Hao; YanMei Yang; Yan Liu; ShuCai Yang; Geng Wang; JianBing Xiao; HuiDong Liu
Journal:  Tumour Biol       Date:  2014-03-02

6.  Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense.

Authors:  Sif Hansdottir; Martha M Monick; Sara L Hinde; Nina Lovan; Dwight C Look; Gary W Hunninghake
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 7.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

Review 8.  Vitamin D for the prevention and treatment of pancreatic cancer.

Authors:  Kun-Chun Chiang; Tai C Chen
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

9.  Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors.

Authors:  Marian L Neuhouser; Bess Sorensen; Bruce W Hollis; Anita Ambs; Cornelia M Ulrich; Anne McTiernan; Leslie Bernstein; Sharon Wayne; Frank Gilliland; Kathy Baumgartner; Richard Baumgartner; Rachel Ballard-Barbash
Journal:  Am J Clin Nutr       Date:  2008-07       Impact factor: 7.045

10.  Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue.

Authors:  Ravi J Menezes; Richard T Cheney; Aliya Husain; Maria Tretiakova; Gregory Loewen; Candace S Johnson; Vijay Jayaprakash; Kirsten B Moysich; Ravi Salgia; Mary E Reid
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-05       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.